本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Collegium Pharmaceutical, Inc.

21.84
-0.9700-4.25%
盤後21.840.00000.00%19:30 EDT
成交量:95.40萬
成交額:2,098.87萬
市值:7.11億
市盈率:17.20
高:22.92
開:22.81
低:21.65
收:22.81
52周最高:50.79
52周最低:21.65
股本:3,255.56萬
流通股本:3,136.51萬
量比:1.04
換手率:3.04%
股息:- -
股息率:- -
每股收益(TTM):1.27
每股收益(LYR):1.73
淨資產收益率:17.61%
總資產收益率:5.75%
市淨率:2.28
市盈率(LYR):12.62

資料載入中...

2026/08/25

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/08/05

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/31

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/06/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors